TOT BIOPHARM International Co. Ltd.(HK:1875)
HK$3.39-0.00 (-0.15%)
HK:1875
TOT BIOPHARM International Co. Ltd. financials statements
HK$3.39
At close:-0.00 (-0.15%)
Want to see HK:1875 full AI Analyst Report?
TOT BIOPHARM International Co. Ltd. (1875) Financial Statements
0 Followers
TOT BIOPHARM International Co. Ltd. Financial Overview
TOT BIOPHARM International Co. Ltd.'s market cap is currently ¥2.62B. The company's EPS TTM is ¥-0.22; its P/E ratio is -13.13; TOT BIOPHARM International Co. Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 747.64M | ¥ 1.10B | ¥ 780.63M | ¥ 442.18M | ¥ 76.33M |
| Gross Profit | ¥ 388.98M | ¥ 782.43M | ¥ 573.99M | ¥ 370.62M | ¥ 27.47M |
| Operating Income | ¥ -90.69M | ¥ 41.25M | ¥ -33.06M | ¥ -39.08M | ¥ -259.70M |
| EBITDA | ¥ -1.29M | ¥ 111.58M | ¥ 10.45M | ¥ -5.41M | ¥ -224.51M |
| Net Income | ¥ -100.37M | ¥ 34.76M | ¥ -37.76M | ¥ -49.92M | ¥ -261.22M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 328.47M | ¥ 381.26M | ¥ 351.60M | ¥ 517.63M | ¥ 155.38M |
| Total Assets | ¥ 1.26B | ¥ 1.51B | ¥ 1.43B | ¥ 1.26B | ¥ 710.26M |
| Total Debt | ¥ 383.72M | ¥ 395.47M | ¥ 345.65M | ¥ 289.53M | ¥ 208.56M |
| Net Debt | ¥ 55.25M | ¥ 14.21M | ¥ -5.95M | ¥ -128.24M | ¥ 55.76M |
| Total Liabilities | ¥ 633.75M | ¥ 779.12M | ¥ 739.41M | ¥ 546.59M | ¥ 375.17M |
| Stockholders' Equity | ¥ 626.08M | ¥ 729.65M | ¥ 686.69M | ¥ 713.88M | ¥ 335.09M |
| Cash Flow | |||||
| Free Cash Flow | ¥ -26.93M | ¥ -7.17M | ¥ -146.77M | ¥ -180.19M | ¥ -290.45M |
| Operating Cash Flow | ¥ 16.14M | ¥ 116.40M | ¥ 56.43M | ¥ 59.93M | ¥ -175.14M |
| Investing Cash Flow | ¥ -43.07M | ¥ -122.50M | ¥ -164.10M | ¥ -282.76M | ¥ -108.39M |
| Financing Cash Flow | ¥ -25.66M | ¥ 34.18M | ¥ 38.23M | ¥ 481.24M | ¥ 212.08M |
Currency in CNY
